Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Incidence of Type 2 Diabetes by Hba1c and Ogtt: The Isfahan Diabetes Prevention Study Publisher Pubmed



Janghorbani M1, 2 ; Amini M2
Authors

Source: Acta Diabetologica Published:2012


Abstract

The aim of this study was to estimate the incidence of type 2 diabetes using newly proposed hemoglobin A1C (HbA1c) and current oral glucose tolerance test (OGTT) definition in an Iranian non-diabetic population. A total of 923 non-diabetic first-degree relatives (FDRs) of patients with type 2 diabetes 30-70 years old in 2003-2005 were followed through 2009 for the occurrence of type 2 diabetes. At baseline and through follow-ups, participants underwent a standard 75 g 2-h OGTT and HbA1c measurements. Prediction of progression to type 2 diabetes by OGTT-defined or HbA1c-defined diabetes was assessed with area under the receiver operating characteristic (ROC) curves based upon measurement of fasting plasma glucose, 2-h post-load glucose values, and HbA1c. The prevalence of type 2 diabetes was 9.2% (95% CI: 8.2, 10.2) by OGTT-defined diabetes and 7.9% (95% CI: 6.9, 9.0) by HbA1c ≥6.5. The incidence of type 2 diabetes was 2.0% (95% CI: 1.6, 2.4) (1.8% men and 2.1% women) per year by the current OGTT definition, whereas the incidence rates were 1.7% (95% CI: 1.3, 2.0) (1.6% men and 1.7% women) per year by HbA1c ≥6.5%. Of those diagnosed with type 2 diabetes by OGTT, 69.6% had HbA1c <6.5% and therefore would not have been classified as having type 2 diabetes. The incidence and prevalence of diabetes using newly proposed HbA1c threshold in this FDRs of patients with type 2 diabetes were slightly lower than using current OGTT definition. © 2011 Springer-Verlag.
Related Docs
View other Related Docs
1. Comparison of Fasting Glucose With Post-Load Glucose Values and Glycated Hemoglobin for Prediction of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Review of Diabetic Studies (2009)
2. Comparison of Glycated Hemoglobin With Fasting Plasma Glucose in Definition of Glycemic Component of the Metabolic Syndrome in an Iranian Population, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2012)
3. Glycated Hemoglobin As a Predictor for Metabolic Syndrome in an Iranian Population With Normal Glucose Tolerance, Metabolic Syndrome and Related Disorders (2012)
Experts (# of related papers)
View all Related Experts
Roya Kelishadi (2)
Awat Feizi (2)
Other Related Docs
4. Comparison of Systolic and Diastolic Blood Pressure With Pulse Pressure and Mean Arterial Pressure for Prediction of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Endokrynologia Polska (2011)
5. Comparison of Metabolic Syndrome With Glucose Measurement for Prediction of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2009)
6. Area Under the Curve During Ogtt in First-Degree Relatives of Diabetic Patients As an Efficient Indicator of Future Risk of Type 2 Diabetes and Prediabetes, Clinical Endocrinology (2017)
7. Effects of Gender and Height on the Oral Glucose Tolerance Test: The Isfahan Diabetes Prevention Study, Review of Diabetic Studies (2008)
8. Effects of Diabetes Definition on Global Surveillance of Diabetes Prevalence and Diagnosis: A Pooled Analysis of 96 Population-Based Studies With 331 288 Participants, The Lancet Diabetes and Endocrinology (2015)
9. Normal Fasting Plasma Glucose and Risk of Prediabetes and Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Review of Diabetic Studies (2011)
10. Diabetes and Impaired Glucose Regulation in First-Degree Relatives of Patients With Type 2 Diabetes in Isfahan, Iran: Prevalence and Risk Factors, Review of Diabetic Studies (2007)
11. The Product of Triglycerides and Glucose in Comparison With Fasting Plasma Glucose Did Not Improve Diabetes Prediction, Acta Diabetologica (2015)
12. Finnish Diabetes Risk Score to Predict Type 2 Diabetes in the Isfahan Diabetes Prevention Study, Diabetes Research and Clinical Practice (2013)
13. Global Variation in Diabetes Diagnosis and Prevalence Based on Fasting Glucose and Hemoglobin A1c, Nature Medicine (2023)
14. Association of Lipid Profile With Type 2 Diabetes in First-Degree Relatives: A 14-Year Follow-Up Study in Iran, Diabetes, Metabolic Syndrome and Obesity (2020)
15. Comparison of Body Mass Index With Abdominal Obesity Indicators and Waist-To-Stature Ratio for Prediction of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Obesity Research and Clinical Practice (2010)
16. The Visceral Adiposity Index in Comparison With Easily Measurable Anthropometric Markers Did Not Improve Prediction of Diabetes, Canadian Journal of Diabetes (2016)
17. Glucose and the Risk of Hypertension in First-Degree Relatives of Patients With Type 2 Diabetes, Hypertension Research (2015)
18. Patterns of Changes in Fasting Plasma Glucose, Hemoglobin A1c and the Area Under the Curve During Oral Glucose Tolerance Tests in Prediabetic Subjects: Results From a 16-Year Prospective Cohort Study Among First-Degree Relatives of Type 2 Diabetic Patients, Acta Diabetologica (2021)
19. Utility of Continuous Metabolic Syndrome Score in Assessing Risk of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Annals of Nutrition and Metabolism (2016)
20. Prevalence and Risk Factors of Diabetes, Pre-Diabetes and Metabolic Syndrome in First-Degree Relatives of Patients With Type Ii Diabetes, Journal of Kerman University of Medical Sciences (2013)